Results 251 to 260 of about 3,380,570 (289)

INTRACELLULAR ANTIBODIES

2001
A method of identifying at least one consensus sequence for an intracellular antibody (ICS) comprising the steps of: creating a database comprising sequences of validated intracellular antibodies (VIDA database) and aligning the sequences of validated intracellular antibodies according to Kabat; determining the frequency with which a particular amino ...
CATTANEO, ANTONINO, MARITAN A, VISINTIN M, RABBITTS T, SETTANNI G.   +4 more
openaire   +5 more sources

Recombinant Antibodies for the Generation of Antibody Arrays

2011
Affinity proteomics, mainly represented by antibody microarrays, has in recent years been established as a powerful tool for high-throughput (disease) proteomics. The technology can be used to generate detailed protein expression profiles, or protein maps, of focused set of proteins in crude proteomes and potentially even high-resolution portraits of ...
Christer Wingren, Carl A.K. Borrebaeck
openaire   +3 more sources

Purification of Antibodies and Preparation of Antibody Fragments

2005
Antibodies may be purified from serum, ascitic fluid, and tissue culture supernatant by a number of methods. Purified antibodies can be treated to produce fragments that may have enhanced properties for use in immunochemistry.
openaire   +3 more sources

Antiphospholipid antibodies and the antiphospholipid antibody syndrome

Journal of the American Academy of Dermatology, 1997
The antiphospholipid antibody syndrome is a multiple-system disorder characterized by persistently elevated antiphospholipid antibodies and/or arterial or venous thrombosis, thrombocytopenia, or recurrent spontaneous abortion. Anticardiolipin antibodies and the lupus anticoagulant are different classes of antiphospholipid antibodies associated with ...
openaire   +3 more sources

Plastic antibodies

Nature Materials, 2010
Imprinting molecular memory on the surface of polymer nanoparticles creates artificial antibodies that can recognize and neutralize a toxic peptide in vivo.
openaire   +4 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Javier Cortés, Giuseppe Curigliano, Paolo Tarantino   +2 more
exaly  

Current treatment and future directions in the management of anal cancer

Ca-A Cancer Journal for Clinicians, 2022
Leila T Tchelebi, Cathy Eng, Craig A Messick   +2 more
exaly  

Modern developments in germline pharmacogenomics for oncology prescribing

Ca-A Cancer Journal for Clinicians, 2022
Natalie M Reizine, Peter H O'donnell
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Avidity in antibody effector functions and biotherapeutic drug design

Nature Reviews Drug Discovery, 2022
Simone C Oostindie, Janine Schuurman, Paul W H I Parren   +2 more
exaly